Results of Adjuvant FOLFOX Regimens in Stage III Colorectal Cancer Patients: Retrospective Analysis of 667 Patients

Publisher： Karger

E-ISSN： 1423-0232|84|4|240-245

ISSN： 0030-2414

Source： Oncology, Vol.84, Iss.4, 2013-02, pp. : 240-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II–III Colorectal Cancer

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 363-368

Karger

Access to resources Recommend Favorite

FOLFOX as Adjuvant Chemotherapy after Curative Resection of Distant Metastases in Patients with Colorectal Cancer

By  

Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. : 84-91

Karger

Access to resources Recommend Favorite

XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis

By Maniadakis Nikos   Fragoulakis Vasilios   Pectasides Dimitrios   Fountzilas George  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 797-805

Informa Healthcare

Access to resources Recommend Favorite

Economic Impact of Alternative Adjuvant Chemotherapy Regimens for Stage III Colon Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 647-652

Karger

Access to resources Recommend Favorite

Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study

By  

Oncology, Vol. 81, Iss. 2, 2011-10 ,pp. : 104-112

Karger

Access to resources Recommend Favorite